Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

AZN

AstraZeneca (AZN)

AstraZeneca PLC

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AZN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
23/10/2023	16h56	Business Wire	Datopotamab deruxtecan improved progression-free survival vs. chemotherapy in patients with previously treated non-small cell lung cancer in TROPION-Lung01 Phase III trial	NASDAQ:AZN	AstraZeneca PLC
23/10/2023	16h50	Business Wire	ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Clinically Meaningful Survival Across Multiple HER2-Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase II Trial	NASDAQ:AZN	AstraZeneca PLC
23/10/2023	16h30	Business Wire	Datopotamab deruxtecan significantly extended progression-free survival vs. chemotherapy in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial	NASDAQ:AZN	AstraZeneca PLC
23/10/2023	08h49	Dow Jones News	AstraZeneca, Daiichi Sankyo's Enhertu Gets Approval in EU For Lung Cancer Treatment	NASDAQ:AZN	AstraZeneca PLC
22/10/2023	13h00	Business Wire	Datopotamab deruxtecan plus IMFINZI® (durvalumab) demonstrated robust and durable tumor responses in 1st-line treatment of patients with metastatic triple-negative breast cancer in BEGONIA Phase Ib/II trial	NASDAQ:AZN	AstraZeneca PLC
21/10/2023	13h05	Business Wire	IMFINZI® (durvalumab) plus LYNPARZA® (olaparib) reduced the risk of disease progression or death by 45% vs. chemotherapy in advanced or recurrent endometrial cancer	NASDAQ:AZN	AstraZeneca PLC
21/10/2023	13h00	Business Wire	TAGRISSO® (osimertinib) plus chemotherapy reduced the risk of disease progression in the brain by 42% in patients with EGFR-mutated advanced lung cancer and brain metastases at baseline	NASDAQ:AZN	AstraZeneca PLC
20/10/2023	14h00	Business Wire	IMFINZI® (durvalumab) plus chemotherapy more than doubled pathologic complete response rate in resectable early-stage gastric and gastroesophageal junction cancers versus chemotherapy alone	NASDAQ:AZN	AstraZeneca PLC
20/10/2023	09h16	KR Market News	머크, 암치료제 개발로 다이이치와 55억 달러 계약 체결	NASDAQ:AZN	AstraZeneca PLC
19/10/2023	14h55	IH Market News	Thursday’s Wall Street Highlights: Netflix, Tesla, SAP, TSMC, Costco, Rentokil, Nokia, and more	NASDAQ:AZN	AstraZeneca PLC
18/10/2023	15h00	GlobeNewswire Inc.	Together for CHANGE Genomics and Equity Initiative Launched by a Coalition of Meharry Medical College, Regeneron Genetics Center, AstraZeneca, Novo Nordisk, and Roche to Improve Health Outcomes for People of African Ancestry	NASDAQ:AZN	AstraZeneca PLC
18/10/2023	14h00	PR Newswire (US)	SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care	NASDAQ:AZN	AstraZeneca PLC
16/10/2023	13h00	Business Wire	TAGRISSO® Plus Chemotherapy Granted Priority Review in the US for Patients with EGFR-Mutated Advanced Lung Cancer	NASDAQ:AZN	AstraZeneca PLC
14/10/2023	14h24	Business Wire	アストラゼネカ、第2回R&Dポスドクチャレンジで世界中の若手研究者に8つの革新的な研究プロジェクトに対する助成金を授与	NASDAQ:AZN	AstraZeneca PLC
12/10/2023	13h47	Business Wire	AstraZeneca subventionne huit projets de recherche innovants menés par des scientifiques en début de carrière du monde entier dans le cadre du deuxième R&D Postdoctoral Challenge	NASDAQ:AZN	AstraZeneca PLC
12/10/2023	13h45	PR Newswire (US)	Fusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2068, a Novel Targeted Alpha Therapy for EGFR-cMET Expressing Cancers	NASDAQ:AZN	AstraZeneca PLC
12/10/2023	13h45	PR Newswire (Canada)	Fusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2068, a Novel Targeted Alpha Therapy for EGFR-cMET Expressing Cancers	NASDAQ:AZN	AstraZeneca PLC
12/10/2023	13h42	Business Wire	AstraZeneca vergibt Fördermittel für acht innovative Forschungsprojekte von Nachwuchswissenschaftlern aus aller Welt im Rahmen des zweiten F&E-Wettbewerbs für Postdoktoranden	NASDAQ:AZN	AstraZeneca PLC
12/10/2023	08h05	Business Wire	AstraZeneca Awards Funding to Eight Innovative Research Projects From Early-Career Scientists Around the World in Second R&D Postdoctoral Challenge	NASDAQ:AZN	AstraZeneca PLC
11/10/2023	13h00	Business Wire	AstraZeneca advances scientific leadership across multiple cancers with first data from four pivotal Phase III trials at ESMO	NASDAQ:AZN	AstraZeneca PLC
10/10/2023	16h30	Business Wire	Astrazeneca Foundation Awards 12 Nonprofit Organizations More Than $2M to Advance Health Equity	NASDAQ:AZN	AstraZeneca PLC
03/10/2023	08h47	Dow Jones News	AstraZeneca Pays $425 Million to Settle Nexium and Prilosec Liability Litigation	NASDAQ:AZN	AstraZeneca PLC
25/09/2023	13h17	IH Market News	Monday’s Wall Street Highlights: Ford, Amazon, Paramount, Nike and more	NASDAQ:AZN	AstraZeneca PLC
22/09/2023	13h29	IH Market News	Friday’s Wall Street Highlights: News Corp, Activision Blizzard, Scholastic, AstraZeneca, Alibaba, and more	NASDAQ:AZN	AstraZeneca PLC
22/09/2023	13h00	Business Wire	Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial	NASDAQ:AZN	AstraZeneca PLC
22/09/2023	08h53	Dow Jones News	AstraZeneca Says Trial Results For Breast Cancer Drug Were Highly Positive	NASDAQ:AZN	AstraZeneca PLC
20/09/2023	08h44	Dow Jones News	AstraZeneca's Rare-Disease Unit Buy Pfizer Portfolio for $1 Billion	NASDAQ:AZN	AstraZeneca PLC
19/09/2023	07h00	Business Wire	AstraZeneca steigert Effizienzen für saubere Wärme und Energie in GB mit Mittelzusagen von 100 Mio. GBP	NASDAQ:AZN	AstraZeneca PLC
15/09/2023	17h00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AZN	AstraZeneca PLC
15/09/2023	16h51	Dow Jones News	AstraZeneca's Lung-Cancer Treatment Gets Recommended for Approval in the EU	NASDAQ:AZN	AstraZeneca PLC

Showing the most relevant articles for your search:NASDAQ:AZN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next >>

Health Care Select Sector

Euro vs Sterling

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen